BIOREXIS TECHNOLOGY INC has a total of 14 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Australia, United States and African Regional Industrial Property Organization. Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are FUNG SEK CHUNG, APPLIED MOLECULAR EVOLUTION INC and TAIWAN ADVANCE BIO PHARM INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | United States | 4 | |
#3 | African Regional Industrial Property Organization | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Animal care | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Sadeghi Homayoun | 9 |
#2 | Prior Christopher P | 8 |
#3 | Turner Andrew | 4 |
#4 | Turner Andrew J | 3 |
#5 | Prior Christopher | 3 |
#6 | Ballance David J | 2 |
#7 | Lai Char-Huei | 1 |
#8 | Char-Huei Lai | 1 |
#9 | Homayoun Sadeghi | 1 |
#10 | Balance David J | 1 |
Publication | Filing date | Title |
---|---|---|
US2011092677A1 | Modified transferin-antibody fusion proteins | |
AP200703920A0 | Combination therapy using transferrin fusion proteins comprising glp-1 | |
US2003221201A1 | Modified transferrin fusion proteins |